Published in Hepatitis Weekly, November 19th, 2001
Final Phase II study results of inoperable primary liver cancer were presented for the first time. Additionally, data from two Phase III studies of IntraDose in head and neck cancer and Phase II studies of metastatic melanoma were presented. IntraDose is a novel drug system designed to provide local control of solid tumors through direct injection while reducing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.